2001 Richard J. Duma/NFID Annual Press Conference and Symposium on Infectious Diseases

Tuesday, June 26, 2001
The National Press Club, First Amendment Room
529 14th Street, NW, Washington, D.C.

Agenda

10:00 a.m.

About the National Foundation for Infectious Diseases (NFID) and the Richard J. Duma/NFID Annual Press Conference and Symposium on Infectious Diseases
Robert A. Whitney, Jr., D.V.M.
National Foundation for Infectious Diseases

10:05 a.m.

Bovine Spongiform Encephalopathy (BSE, Mad Cow Disease)--Ongoing Health Concerns in the United States and Europe
Robert A. Whitney, Jr., D.V.M.
National Foundation for Infectious Diseases
Bethesda, MD

Linda Detwiler, D.V.N.
Animal and Plant Health Inspection Service
US Department of Agriculture

David M. Asher, M.D.
Center for Biologics Evaluation and Research
US Food and Drug Administration

10:25 a.m.

Questions and Answers

10:30 a.m.

Is the United States Prepared to Handle Imported Cases of Hemorrhagic Fever?
T.G. Ksiazek, D.V.M., Ph.D.
National Center for Infectious Diseases
Centers for Disease Control and Prevention
Atlanta, Georgia

10:50 a.m.

Questions and Answers

10:55 a.m.

Antibiotic Use and Resistance--Reaching the Tipping Point?
John E. McGowan, Jr., M.D.
Rollins School of Public Health
Emory University School of Medicine
Atlanta, Georgia

11:15 a.m.

Questions and Answers

11:20 a.m.

Vaccine Safety--Current Issues and How to Deal with Conflicting Information
R. Gordon Douglas, Jr., M.D.
Princeton, NJ

11:40 a.m.

Questions and Answers

11:45 a.m.

Panel Discussion
Moderator--Richard J. Duma, M.D., Ph.D.
Halifax Medical Center
Daytona Beach, Florida

Each panelist will be asked for his/her prediction about breaking infectious disease news for 2002, followed by questions from the audience.

12:00 p.m.

Adjournment/Complimentary Lunch

Presented by the National Foundation for Infectious Diseases with the support of unrestricted educational grants from:

AlphaVax Human Vaccines, Inc.
AstraZeneca Pharmaceuticals
Aventis Pharmaceuticals
Biotechnology Industry Organization
Cubist Pharmaceuticals, Inc.
Merck Vaccine Division
Ortho-McNeil Pharmaceutical
Wyeth-Lederle Vaccines